Inventor
Sangeeta Ray
Inventor
Ellicott City, MD, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07DHeterocyclic compounds16%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
C07CAcyclic or carbocyclic compounds5%
C07KPeptides5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
A61BDiagnosis2%
PatentTitleYear
10,857,246Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase IX and uses thereof202010,736,974Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy202010,717,75068Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agents202010,688,198Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereof202010,683,272Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy202010,653,806Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof202010,369,113Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer201910,188,754Compositions and methods for chemical exchange saturation transfer (CEST) based magnetic resonance imaging (MRI)201910,039,845Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents201810,029,023Theranostic imaging agents and methods of use20189,884,132'Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof'20189,776,977'PSMA-targeting compounds and uses thereof'20179,694,091'Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents'20179,422,234'Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer'20169,371,360'Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2020Patents assigned to UNIV JOHNS HOPKINS (15)· patent assignee history
2016–2018Patents assigned to RAY SANGEETA (2)· patent assignee history
2016Patents assigned to CHANDRAN SACHIN S (1)· patent assignee history
2016–2020Based in Ellicott City, MD, US· patent location history
2018Patents assigned to BHUJWALLA ZAVER (1)· patent assignee history
2018Patents assigned to CHEN ZHIHANG (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV JOHNS HOPKINS | 15 | 2016–2020 |
| RAY SANGEETAself | 2 | 2016–2018 |
| BHUJWALLA ZAVER | 1 | 2018 |
| CHANDRAN SACHIN S | 1 | 2016 |
| CHEN ZHIHANG | 1 | 2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ellicott City, Maryland, US | 15 | 2016–2020 |